These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Molecular docking studies of fused coumarin derivatives as inhibitors of GlcN-6.
    Author: Govori S, Haziri A, Ademi K, Neziraj N.
    Journal: J Environ Sci Health A Tox Hazard Subst Environ Eng; 2017 Sep 19; 52(11):1041-1045. PubMed ID: 28737449.
    Abstract:
    The biological activity of heterocyclic compounds depends on their structure, the type of hetero atoms in the ring and on the type of substituents present. In this paper, some heterocyclic compounds with coumarin moieties S1-S5 and novobiocin known as coumarin antibiotic were subjected to the molecular docking studies as important tools for drug discovery. Glucosamine-6-phosphate synthase is selected as a suitable target in this study. In silico studies reveal that all synthesized compounds S1-S5 are good inhibitors of GlcN-6 and the docking results are in agreement with in vitro antibacterial evaluation of compounds S1-S5.
    [Abstract] [Full Text] [Related] [New Search]